Hugo Aerts

Research activity per year

122 Article
8 (Systematic) Review article
6 Preprint
3 Conference article in proceeding
More

2 results

Filter

2024
Author Correction: The evolution of lung cancer and impact of subclonal selection in TRACERx (Nature, (2023), 616, 7957, (525-533), 10.1038/s41586-023-05783-5)
Frankell, A. M., Dietzen, M., Al Bakir, M., Lim, E. L., Karasaki, T., Ward, S., Veeriah, S., Colliver, E., Huebner, A., Bunkum, A., Hill, M. S., Grigoriadis, K., Moore, D. A., Black, J. R. M., Liu, W. K., Thol, K., Pich, O., Watkins, T. B. K., Naceur-Lombardelli, C. & Cook, D. E. & 32 others, Salgado, R., Wilson, G. A., Bailey, C., Angelova, M., Bentham, R., Martínez-Ruiz, C., Abbosh, C., Nicholson, A. G., Le Quesne, J., Biswas, D., Rosenthal, R., Puttick, C., Hessey, S., Lee, C., Prymas, P., Toncheva, A., Smith, J., Xing, W., Nicod, J., Price, G., Kerr, K. M., Naidu, B., Middleton, G., Blyth, K. G., Fennell, D. A., Forster, M. D., Lee, S. M., Falzon, M., Hewish, M., Shackcloth, M. J., TRACERx Consortium & Aerts, H. J. W. L., 25 Jul 2024, In: Nature. 631, 8022, p. E15
Research output: Contribution to journal › Erratum / corrigendum / retractions › Academic

Open Access
2017
Corrigendum to “Externally validated HPV-based prognostic nomogram for oropharyngeal carcinoma patients yields more accurate predictions than TNM staging” [Radiother Oncol 113 (2014) 324–30]
Velazquez, E. R., Hoebers, F., Aerts, H. J. W. L., Rietbergen, M. M., Brakenhoff, R. H., Leemans, R. C., Speel, E.-J., Straetmans, J., Kremer, B. & Lambin, P., Aug 2017, In: Radiotherapy and Oncology. 124, 2, p. 337-338 2 p.
Research output: Contribution to journal › Erratum / corrigendum / retractions › Academic

Open Access
File
49 Downloads (Pure)

Hugo Aerts

Research output

Search results

Author Correction: The evolution of lung cancer and impact of subclonal selection in TRACERx (Nature, (2023), 616, 7957, (525-533), 10.1038/s41586-023-05783-5)

Corrigendum to “Externally validated HPV-based prognostic nomogram for oropharyngeal carcinoma patients yields more accurate predictions than TNM staging” [Radiother Oncol 113 (2014) 324–30]